Lower plasma DHA and EPA and their related oxylipins are potential contributors to vascular disease in hemodialysis patients

Authors :: Shaun Kaiser
Theresa L. Pedersen
Allon N. Friedman
Yong Li
John W. Newman
Jeffrey Kim
Bruce A. Watkins
Source :: The FASEB Journal. 27
Publication Year :: 2013
Publisher :: Wiley, 2013.

Subjects :: medicine.medical_specialty
business.industry
Vascular disease
medicine.medical_treatment
medicine.disease
Biochemistry
Gastroenterology
Internal medicine
Genetics
medicine
Hemodialysis
business
Molecular Biology
Biotechnology

Tools